Julia Schüler Selected Research

Julia Schüler Research Topics

Disease

23	Neoplasms (Cancer) 04/2022 - 05/2007
3	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 02/2015
2	Carcinogenesis 04/2022 - 06/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 06/2015
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 06/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2021 - 08/2014
2	Lung Neoplasms (Lung Cancer) 01/2021 - 05/2011
2	Adenocarcinoma 01/2021 - 05/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2019 - 12/2015
2	Lymphoma (Lymphomas) 05/2015 - 07/2012
2	Liver Neoplasms (Liver Cancer) 12/2014 - 01/2013
2	Hepatocellular Carcinoma (Hepatoma) 12/2014 - 01/2012
1	Hypoxia (Hypoxemia) 02/2022
1	Emotional Exhaustion 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019
1	Acinar Cell Carcinoma 10/2016
1	Adenocarcinoma of Lung 12/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2013
1	Immunoglobulin Light-chain Amyloidosis 04/2013
1	Multiple Myeloma 04/2013
1	Burkitt Lymphoma (Burkitt's Lymphoma) 07/2012
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2011
1	Neoplasm Metastasis (Metastasis) 12/2009

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 04/2022 - 05/2007
4	Messenger RNA (mRNA)IBA 01/2022 - 05/2007
3	EpitopesIBA 06/2015 - 07/2012
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2017
2	Biological ProductsIBA 04/2022 - 01/2017
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2021 - 01/2021
2	Taxoids (Taxanes)IBA 01/2021 - 01/2017
2	Docetaxel (Taxotere)FDA Link 01/2017 - 01/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 02/2015
2	Histone Deacetylase InhibitorsIBA 12/2015 - 06/2015
2	4-methylthiobutyl isothiocyanateIBA 12/2014 - 01/2013
1	Ouabain (G Strophanthin)IBA 02/2022
1	EmetineIBA 02/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022
1	IntegrinsIBA 01/2022
1	LigandsIBA 01/2022
1	Cyclin BIBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2021
1	UbiquitinIBA 01/2021
1	Anaphase-Promoting Complex-CyclosomeIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	N- propyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (PPTP)IBA 01/2021
1	AntigensIBA 01/2021
1	Ligases (Synthetase)IBA 01/2021
1	Antimitotic AgentsIBA 01/2021
1	BuffersIBA 01/2021
1	CytokinesIBA 10/2019
1	Interleukin-2 (IL2)IBA 10/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2019
1	Hematoxylin (Haematoxylon)IBA 07/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	navitoclaxIBA 01/2019
1	venetoclaxIBA 01/2019
1	AndrogensIBA 01/2017
1	taxaneIBA 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2016
1	Lipase (Acid Lipase)FDA Link 10/2016
1	ChromatinIBA 12/2015
1	PanobinostatIBA 12/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2015
1	mocetinostatIBA 06/2015
1	Capsules (Microcapsules)IBA 05/2015
1	Testosterone (Sustanon)FDA Link 05/2015
1	PhosphotyrosineIBA 02/2015
1	Hormones (Hormone)IBA 02/2015
1	ProteomeIBA 02/2015
1	nilotinib FDA Link 02/2015
1	Tyrosine Kinase InhibitorsIBA 02/2015
1	sulforaphaneIBA 12/2014
1	tetra(4-N-methylpyridyl)porphineIBA 12/2014
1	isothiocyanic acidIBA 12/2014
1	erucinIBA 12/2014
1	EnzymesIBA 12/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2014
1	Aligeron (AS 2)IBA 02/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2013
1	Insulin (Novolin)FDA Link 08/2013
1	Sorafenib (BAY 43-9006)FDA Link 04/2013
1	IsothiocyanatesIBA 01/2013
1	PhytochemicalsIBA 01/2013
1	Peptides (Polypeptides)IBA 07/2012
1	Cetuximab (Erbitux)FDA Link 05/2011
1	ErbB Receptors (EGF Receptor)IBA 05/2011
1	Zinc Finger E-box-Binding Homeobox 1IBA 12/2009
1	Cytotoxins (Cytolysins)IBA 05/2007

Therapy/Procedure

9	Therapeutics 02/2022 - 05/2011
3	Drug Therapy (Chemotherapy) 02/2022 - 02/2015
1	Investigational Therapies (Experimental Therapy) 01/2021
1	Immunotherapy 01/2021
1	Prostatectomy (Retropubic Prostatectomy) 05/2015
1	Heterologous Transplantation (Xenotransplantation) 05/2015